ArticleDrug design, development and therapy2021

CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma.

Junwu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.